scholarly journals The Impact of Human Immunodeficiency Virus Exposure on Respiratory Syncytial Virus–associated Severe Respiratory Illness in South African Infants, 2011–2016

2019 ◽  
Vol 69 (12) ◽  
pp. 2208-2211
Author(s):  
Meredith L McMorrow ◽  
Stefano Tempia ◽  
Sibongile Walaza ◽  
Florette K Treurnicht ◽  
Jocelyn Moyes ◽  
...  

Abstract From 2011 through 2016, we conducted surveillance for severe respiratory illness in infants. Human immunodeficiency virus exposure significantly increased the risk of respiratory syncytial virus (RSV)–associated hospitalization in infants aged <5 months. More than 60% of RSV-associated hospitalizations occurred in the first 4 months of life and may be preventable through maternal vaccination or birth-dose monoclonal antibody.

Author(s):  
Bryan O Nyawanda ◽  
Nancy A Otieno ◽  
Michael O Otieno ◽  
Gideon O Emukule ◽  
Godfrey Bigogo ◽  
...  

Abstract Background Respiratory syncytial virus (RSV) is an important cause of respiratory illness worldwide; however, burden data on mother–infant pairs remain sparse in sub-Saharan Africa, where human immunodeficiency virus (HIV) is prevalent. We evaluated the impact of maternal HIV infection on the burden of RSV among mothers and their infants in western Kenya. Methods We enrolled pregnant women (≤20 weeks’ gestation) and followed them and their newborns weekly for up to 3–6 months postpartum, to document cases of acute respiratory illness (ARI). Nasal/oropharyngeal swabs were collected and tested for RSV using polymerase chain reaction. Analyses were stratified by maternal HIV status and incidence was computed per 1000 person-months. Results Compared to RSV-negative ARI cases, RSV-positive cases were associated with cough, apnea, and hospitalization among infants. RSV incidence per 1000 person-months among mothers was 4.0 (95% confidence interval [CI], 3.2–4.4), and was twice that among the HIV-infected mothers (8.4 [95% CI, 5.7–12.0]) compared to the HIV-uninfected mothers (3.1 [95% CI, 2.3–4.0]). Among infants, incidence per 1000 person-months was 15.4 (95% CI, 12.5–18.8); incidence did not differ by HIV exposure or prematurity. Conclusions HIV infection may increase the risk of RSV illness among pregnant women. Future maternal RSV vaccines may have added benefit in areas with high HIV prevalence.


1990 ◽  
Vol 117 (2) ◽  
pp. 251-254 ◽  
Author(s):  
Sulachni Chandwani ◽  
William Borkowsky ◽  
Keith Krasinski ◽  
Robert Lawrence ◽  
Robert Welliver

Sign in / Sign up

Export Citation Format

Share Document